A 105 (+2.13%)
US00846U1016Medical Diagnostics & ResearchDiagnostics & Research

Agilent Technologies (A) Competitor Comparison

We are evaluating the key criteria listed to compare Agilent Technologies (A) against its competitors in the Diagnostics & Research industry.

Linearity 10 years - A ranking 31 / 58

These are the competitors of Agilent Technologies in the industry Diagnostics & Research ranked by linearity 10 years
1. Inotiv NOTV
35.27
2. Ortho Clinical Diagnostics Holdings OCDX
33.4
3. National Research NRC
17.65
4. Charles River Laboratories CRL
11.37
5. Anixa Biosciences ANIX
10.07
6. Guardant Health GH
9.14
7. Olink Holding OLK
8.11
8. NeoGenomics NEO
6.78
9. Exact Sciences EXAS
5.72
10. Fulgent Genetics FLGT
5.68
11. Global Cord Blood CO
5.67
12. Neogen NEOG
5.1
13. Illumina ILMN
5.05
14. DarioHealth DRIO
4.86
15. Pacific Biosciences of California PACB
4.67
16. Qiagen QGEN
4.29
17. Icon ICLR
3.9
18. Syneos Health SYNH
3.71
19. Twist Bioscience TWST
3.48
20. Co-Diagnostics CODX
3.21
21. Sotera Health SHC
3.17
22. IQVIA Holdings IQV
3.1
23. Enzo Biochem ENZ
3.08
24. Myriad Genetics MYGN
2.94
25. CareDx CDNA
2.68
26. Bioventus BVS
2.51
27. Psychemedics PMD
2.39
28. Exagen XGN
2.32
29. Aspira Womens Health AWH
2.28
30. Sera Prognostics SERA
2.24
31. Agilent Technologies A
2.17
32. Laboratory Corp of America Holdings LH
2.11
33. Meridian Bioscience VIVO
2.1
34. MaxCyte MXCT
1.92
35. MDxHealth MDXH
1.91
36. bioAffinity Technologies BIAF
1.9
37. Biodesix BDSX
1.87
38. Personalis PSNL
1.84
39. Prenetics Global PRE
1.72
40. Organovo Holdings ONVO
1.66
41. Mettler-Toledo MTD
1.66
42. Neuronetics STIM
1.62
43. Quest Diagnostics DGX
1.59
44. Trinity Biotech TRIB
1.57
45. DexCom DXCM
1.56
46. Waters WAT
1.47
47. Thermo Fisher Scientific TMO
1.45
48. Danaher DHR
1.43
49. SeqLL SQL
1.42
50. Interpace Biosciences IDXG
1.33
51. PerkinElmer PKI
1.15
52. Precipio PRPO
1.05
53. IDEXX Laboratories IDXX
0.94
54. Heska HSKA
0.52
55. Natera NTRA
0.4
56. Lantheus Holdings LNTH
0.32
57. RadNet RDNT
0.29
58. Medpace Holdings MEDP
0.25

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.